vimarsana.com
Home
Live Updates
Dr Scott Soefje Says New Biosimilar Workflow "Completely Sim
Dr Scott Soefje Says New Biosimilar Workflow "Completely Sim
Dr Scott Soefje Says New Biosimilar Workflow "Completely Simplified the System"
Scott Soefje, PharmD, director of pharmacy cancer care at Mayo Clinic, explains how education can help with biosimilar adoption and how an updated biosimilar workflow has simplified the prior authorization process.
Related Keywords
Scott Soefje ,
,
Biosimilars ,
Workflow ,
Mayo Clinic ,
Education ,
Pharmacy ,